Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has enrolled its first cohort of 30 participants into the Travelan® clinical trial to evaluate its efficacy to prevent.
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has received US Army Medical Research and Development Command (USAMRDC) Office of Human and Animal Research Oversight.
US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™ Achieves 150 Recruitment Milestone streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
US recruitment milestone for trial of Immuron s Travelan miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Highlights: First participants enrolled in USU Travelan Clinical Trial Field Study157 participants successfully randomized into the Clinical StudyPlans in place to enrol in 1302 healthy volunteers in. | January 18, 2023